-
Interferon-gamma signs off an old heart. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-15 Daniel Harding,Federica Marelli-Berg
-
Should we resurrect acetazolamide as a diuretic for congestion due to heart failure? Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-15 Joe J Cuthbert,John G F Cleland
-
Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-15 Francesco Corradi,Gabriele Masini,Tonino Bucciarelli,Raffaele De Caterina
Systemic iron deficiency (SID), even in the absence of anaemia, worsens the prognosis and increases mortality in heart failure (HF). Recent clinical-epidemiological studies, however, have shown that a myocardial iron deficiency (MID) is frequently present in cases of severe HF, even in the absence of SID and without anaemia. In addition, experimental studies have shown a poor correlation between the
-
Can a genetic mutation associated with glycosuria teach us about the action of sodium-glucose cotransporter-2 inhibitors? Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-15 Jonathan Golledge
-
Crosstalk of platelets with macrophages and fibroblasts aggravates inflammation, aortic wall stiffening and osteopontin release in abdominal aortic aneurysm Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-15 M U Wagenhäuser, J Mulorz, K J Krott, A Ehrenberg, T Feige, Y H Rhee, M Chatterjee, N Petzold, C Böddeker, W Ibing, I Krüger, A M Popovic, J M Spin, P S Tsao, A Roseman, H Schelzig, M Elvers
Aims Abdominal aortic aneurysm (AAA) is a highly lethal disease with progressive dilatation of the abdominal aorta accompanied by degradation and remodelling of the vessel wall due to chronic inflammation. Platelets play an important role in cardiovascular diseases but their role in AAA is poorly understood. Methods and Results The present study revealed that platelets play a crucial role in promoting
-
Acute heart failure: mechanisms and pre-clinical models—a Scientific Statement of the ESC Working Group on Myocardial Function Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-15 Michele Ciccarelli, Inês Falcão Pires, Johann Bauersachs, Luc Bertrand, Christophe Beauloye, Dana Dawson, Nazha Hamdani, Denise Hilfiker-Kleiner, Linda W van Laake, Frank Lezoualc’h, Wolfgang A Linke, Ida G Lunde, Peter P Rainer, Antonella Rispoli, Valeria Visco, Albino Carrizzo, Matteo Dal Ferro, Davide Stolfo, Jolanda van der Velden, Serena Zacchigna, Stephane Heymans, Thomas Thum, Carlo Gabriele
While chronic heart failure (CHF) treatment has considerably improved patient prognosis and survival, the therapeutic management of acute heart failure (AHF) has remained virtually unchanged in the last decades. This is partly due to the scarcity of pre-clinical models for the pathophysiological assessment and, consequently, the limited knowledge of molecular mechanisms involved in the different AHF
-
Targeting the apelin system for the treatment of cardiovascular diseases Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-13 Fiona A Chapman, Janet J Maguire, David E Newby, Anthony P Davenport, Neeraj Dhaun
Cardiovascular disease is the leading cause of death worldwide. Its prevalence is rising due to ageing populations and the increasing incidence of diseases such as chronic kidney disease, obesity and diabetes which are associated with elevated cardiovascular risk. Despite currently available treatments, there remains a huge burden of cardiovascular disease-associated morbidity for patients and healthcare
-
Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-07 Runzhu Shi, Marius Reichardt, Dominik J Fiegle, Linda K Küpfer, Titus Czajka, Zhengwu Sun, Tim Salditt, Andreas Dendorfer, Thomas Seidel, Tobias Bruegmann
Aims Cardiotoxicity is one major reason why drugs do not enter or are withdrawn from the market. Thus, approaches are required to predict cardiotoxicity with high specificity and sensitivity. Ideally, such methods should be performed within intact cardiac tissue with high relevance for humans and detect acute and chronic side effects on electrophysiological behaviour, contractility, and tissue structure
-
The inhibition of inner mitochondrial fusion in hepatocytes reduces NAFL and improves metabolic profile during obesity by modulating bile acid conjugation Cardiovasc. Res. (IF 10.8) Pub Date : 2023-11-03 Lorenzo Da Dalt, Annalisa Moregola, Monika Svecla, Silvia Pedretti, Francesca Fantini, Mirko Ronzio, Patrizia Uboldi, Diletta Dolfini, Elena Donetti, Andrea Baragetti, Nico Mitro, Luca Scorrano, Giuseppe Danilo Norata
Background and aim Mitochondria are plastic organelles that continuously undergo biogenesis, fusion, fission, and mitophagy to control cellular energy metabolism, calcium homeostasis, hormones, sterols and bile acids (BAs) synthesis. Here we evaluated how the impairment of mitochondrial fusion in hepatocytes affect diet induced liver steatosis and obesity. Methods and Results Male mice selectively
-
Deletion of adipocyte NOS3 potentiates high-fat diet-induced hypertension and vascular remodeling via chemerin Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-28 Andy W C Man, Yawen Zhou, Gisela Reifenberg, Alica Camp, Thomas Münzel, Andreas Daiber, Ning Xia, Huige Li
Aims Obesity is an epidemic that is a critical contributor to hypertension and other cardiovascular diseases. Current paradigms suggest that endothelial nitric oxide synthase (eNOS/NOS3) in the vessel wall is the primary regulator of vascular function and blood pressure. However, recent studies have revealed the presence of eNOS/NOS3 in the adipocytes of white adipose tissues and perivascular adipose
-
Exercise-induced circular RNA circUtrn is required for cardiac physiological hypertrophy and prevents myocardial ischemia-reperfusion injury Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-28 Lijun Wang, Jingyi Feng, Xing Feng, Danni Meng, Xuan Zhao, Jiaqi Wang, Pujiao Yu, Gui-e Xu, Meiyu Hu, Tianhui Wang, H Immo Lehmann, Guoping Li, Joost P G Sluijter, Junjie Xiao
Aims Regular exercise training benefits cardiovascular health and effectively reduces the risk for cardiovascular disease. Circular RNAs (circRNAs) play important roles in cardiac pathophysiology. However, the role of circRNAs in response to exercise training and biological mechanisms responsible for exercise-induced cardiac protection remain largely unknown. Methods and results RNA sequencing was
-
Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large scale observational and Mendelian randomization evidence Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-27 Maria Booth Nielsen, Yunus Çolak, Marianne Benn, Amy Mason, Stephen Burgess, Børge Grønne Nordestgaard
Aims Adiponectin may play an important protective role in heart failure and associated cardiovascular diseases. We hypothesized that plasma adiponectin is associated observationally and causally, genetically with risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction. Methods and results In the Copenhagen General Population Study, we examined 30,045 individuals
-
Efficacy of pharmacological and interventional treatment for resistant hypertension-a network meta-analysis Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-27 Zhejia Tian, Clara Vollmer Barbosa, Hannah Lang, Johann Bauersachs, Anette Melk, Bernhard M W Schmidt
Aims Resistant hypertension is associated with a high risk of cardiovascular disease, chronic kidney disease and mortality. Yet, its management is challenging. This study aims to establish the comparative effectiveness of pharmacologic and interventional treatments by conducting a network meta-analysis. Methods and Results MEDLINE, Cochrane Register of Controlled Trials and Web of Science Core Collection
-
RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicing Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-27 Peiheng Gan, Zhaoning Wang, Svetlana Bezprozvannaya, John R McAnally, Wei Tan, Hui Li, Rhonda Bassel-Duby, Ning Liu, Eric N Olson
Aims RNA binding proteins play essential roles in mediating RNA splicing and are key post-transcriptional regulators in the heart. Our recent study demonstrated that RBPMS (RNA-binding protein with multiple splicing) is crucial for cardiac development through modulating mRNA splicing, but little is known about its functions in the adult heart. In this study, we aim to characterize the postnatal cardiac
-
Point mutations in RyR2 Ca2+ binding residues of human cardiomyocytes cause cellular remodeling of cardiac EC-coupling Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-26 Yanli Xia, Xiao-hua Zhang, Naohiro Yamaguchi, Martin Morad
Aims CRISPR/Cas9 gene-edits of cardiac ryanodine receptor (RyR2) in human induced pluripotent stem cells derived-cardiomyocytes (hiPSC-CMs) provides a novel platform for introducing mutations in RyR2 Ca2+ binding residues and examining the resulting EC-coupling remodeling consequences. Methods and Results Ca2+-signaling phenotypes of mutations in RyR2 Ca2+ binding site residues associated with cardiac
-
Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-25 Maria Borrell-Pages, Aureli Luquero, Gemma Vilahur, Teresa Padró, Lina Badimon
Objective There is little information on the regulation of cholesterol homeostasis in the brain. Whether cholesterol crosses the blood-brain barrier is under investigation, but the present understanding is that cholesterol metabolism in the brain is independent from that in peripheral tissues. Lipoprotein receptors from the LDL receptor family (LRPs) have key roles in lipid particle accumulation in
-
Updating the paradigm: inflammation as a targetable modulator of medial vascular calcification. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-24 Mandy E Turner,Elena Aikawa
-
LDL's unexpected travel partners in the road to atherosclerosis. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-24 Soumaya Ben-Aicha,Borja Ibañez
-
Triggering receptor expressed on myeloid cells 2 restricts cardiac inflammation and hypertrophy in hypertensive mice. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-24 Murilo Delgobo,Stefan Frantz
-
TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-24 Filip Rolski, Karolina Tkacz, Kazimierz Węglarczyk, Grzegorz Kwiatkowski, Paweł Pelczar, Agnieszka Jaźwa-Kusior, Anna Bar, Gabriela M Kuster, Stefan Chłopicki, Maciej Siedlar, Gabriela Kania, Przemysław Błyszczuk
Background and aims Tumour necrosis factor α (TNF-α) represents a classical proinflammatory cytokine and its increased levels positively correlate with the severity of many cardiovascular diseases. Surprisingly, some heart failure patients receiving high doses of anti- TNF-α antibodies showed serious health worsening. This work aimed to examine the role of TNF-α signalling on the development and progression
-
Cardioprotection in cardio-oncology: a case for concern? Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-16 Gerd Heusch
-
Prdm16 mutation determines sex-specific cardiac metabolism and identifies two novel cardiac metabolic regulators Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-16 Jirko Kühnisch, Simon Theisen, Josephine Dartsch, Raphaela Fritsche-Guenther, Marieluise Kirchner, Benedikt Obermayer, Anna Bauer, Anne-Karin Kahlert, Michael Rothe, Dieter Beule, Arnd Heuser, Philipp Mertins, Jennifer A Kirwan, Nikolaus Berndt, Calum A MacRae, Norbert Hubner, Sabine Klaassen
Aims Mutation of the PRDM16 gene causes human dilated and non-compaction cardiomyopathy. The PRDM16 protein is a transcriptional regulator that affects cardiac development via Tbx5 and Hand1, thus regulating myocardial structure. The biallelic inactivation of Prdm16 induces severe cardiac dysfunction with post-natal lethality and hypertrophy in mice. The early pathological events that occur upon Prdm16
-
Empagliflozin improves cardiac energetics during ischaemia/reperfusion by directly increasing cardiac ketone utilisation Cardiovasc. Res. (IF 10.8) Pub Date : 2023-10-11 Dylan Chase, Thomas R Eykyn, Michael J Shattock, Yu Jin Chung
AIM Empagliflozin (EMPA), a potent inhibitor of the renal sodium-glucose cotransporter 2 (SGLT2) and an effective treatment for type-2 diabetes, has been shown to have cardioprotective effects, independent of improved glycaemic control. Several non-canonical mechanisms have been proposed to explain these cardiac effects, including increasing circulating ketone supply to the heart. This study aims to
-
-
Targeting Galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-09-29 Nikolaos G Frangogiannis
-
Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans Cardiovasc. Res. (IF 10.8) Pub Date : 2023-09-22 Simon Kraler, Carolina Balbi, Daria Vdovenko, Tetiana Lapikova-Bryhinska, Giovanni G Camici, Luca Liberale, Nicole Bonetti, Candela Diaz Canestro, Fabienne Burger, Aline Roth, Federico Carbone, Giuseppe Vassalli, François Mach, Shalender Bhasin, Florian A Wenzl, Olivier Muller, Lorenz Räber, Christian M Matter, Fabrizio Montecucco, Thomas F Lüscher, Alexander Akhmedov
Aims The heart rejuvenating effects of circulating growth differentiation factor 11 (GDF11), a TGF-β superfamily member that shares 90% homology with myostatin (MSTN), remains controversial. Here, we aimed to probe the role of GDF11 in acute myocardial infarction (MI), a frequent cause of heart failure and premature death during ageing. Methods and results In contrast to endogenous Mstn, myocardial
-
Targeted activation of hERG channels rescues electrical instability induced by the hERG R56Q+/- Long QT Syndrome variant Cardiovasc. Res. (IF 10.8) Pub Date : 2023-09-20 R Venkateshappa, D V Hunter, P Muralidharan, R S Nagalingam, G Huen, S Faizi, S Luthra, E Lin, Y M Cheng, J Hughes, R Khelifi, P Dhunna, R Johal, V Sergeev, S Shafaattalab, L M Julian, D T Poburko, Z Laksman, G F Tibbits, T W Claydon
Aims Long QT Syndrome Type 2 (LQTS2) is associated with inherited variants in the cardiac hERG K+ channel. However, the pathogenicity of hERG channel gene variants is often uncertain. Using CRISPR-Cas9 gene-edited hiPSC-derived cardiomyocytes (hiPSC-CMs), we investigated the pathogenic mechanism underlying the LQTS-associated hERG R56Q variant, and its phenotypic rescue by the type 1 hERG activator
-
Cardiomyocyte and endothelial cells play distinct roles in the tumor necrosis factor (TNF)-dependent atrial responses and increased atrial fibrillation vulnerability induced by endurance exercise training in mice Cardiovasc. Res. (IF 10.8) Pub Date : 2023-09-15 Robert Lakin, Nazari Polidovitch, Sibao Yang, Mihir Parikh, Xueyan Liu, Ryan Debi, Xiaodong Gao, Wenliang Chen, Camilo Guzman, Simona Yakobov, Farzad Izaddoustdar, Marianne Wauchop, Qian Lei, Weimin Xu, Sergei A Nedospasov, Vincent M Christoffels, Peter H Backx
Aims Endurance exercise is associated with an increased risk of atrial fibrillation (AF). We previously established that adverse atrial remodeling and AF susceptibility induced by intense exercise in mice requires the mechanosensitive and pro-inflammatory cytokine tumor necrosis factor (TNF). The cellular and mechanistic basis for these TNF-mediated effects is unknown. Methods and Results We studied
-
Metabolic targeting of platelets to combat thrombosis: dawn of a new paradigm? Cardiovasc. Res. (IF 10.8) Pub Date : 2023-09-12 Gagan D Flora, Manasa K Nayak, Madankumar Ghatge, Anil K Chauhan
Current antithrombotic therapies used in clinical settings either target the coagulation pathways or platelet activation receptors (P2Y12 or GPIIb/IIIa), as well as the cyclooxygenase (COX) enzyme through aspirin. However, they are associated with bleeding risk and are not suitable for long-term use. Thus, novel strategies which provide broad protection against platelet activation with minimal bleeding
-
Predictive metabolites for incident myocardial infarction: a two-step meta-analysis of individual patient data from six cohorts comprising 7,897 individuals from the the COnsortium of METabolomic Studies Cardiovasc. Res. (IF 10.8) Pub Date : 2023-09-12 Ana Nogal, Taryn Alkis, Yura Lee, Domagoj Kifer, Jie Hu, Rachel A Murphy, Zhe Huang, Rui Wang-Sattler, Gabi Kastenmüler, Birgit Linkohr, Clara Barrios, Marta Crespo, Christian Gieger, Annette Peters, Jackie Price, Kathryn M Rexrode, Bing Yu, Cristina Menni
Aims Myocardial infarction (MI) is a major cause of death and disability worldwide. Most metabolomics studies investigating metabolites predicting MI are limited by the participant number and/or the demographic diversity. We sought to identify biomarkers of incident MI in the Consortium of Metabolomics Studies (COMETS). Methods and Results We included 7,897 individuals aged on average 66 years from
-
Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development Cardiovasc. Res. (IF 10.8) Pub Date : 2023-09-05 Fitzwilliam Seibertz, Tony Rubio, Robin Springer, Fiona Popp, Melanie Ritter, Aiste Liutkute, Lena Bartelt, Lea Stelzer, Fereshteh Haghighi, Jan Pietras, Hendrik Windel, Núria Díaz i Pedrosa, Markus Rapedius, Yannic Döring, Richard Solano1, Robin Hindmarsh, Runzhu Shi, Malte Tiburcy, Tobias Brügmann, Ingo Kutschka, Katrin Streckfuss-Bömeke, George Kensah, Lukas Cyganek, Wolfram H Zimmermann, Niels
Background and Aims Atrial fibrillation (AF) is associated with tachycardia-induced cellular electrophysiology alterations which promote AF chronification and treatment resistance. Development of novel antiarrhythmic therapies is hampered by the absence of scalable experimental human models that reflect AF-associated electrical remodelling. Therefore, we aimed to assess if AF-associated remodelling
-
Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-29 Badder Kattih, Felicitas Boeckling, Mariana Shumliakivska, Lukas Tombor, Tina Rasper, Katja Schmitz, Jedrzej Hoffmann, Luka Nicin, Wesley T Abplanalp, Daniel C Carstens, Mani Arsalan, Fabian Emrich, Tomas Holubec, Thomas Walther, Valentina O Puntmann, Eike Nagel, David John, Andreas M Zeiher, Stefanie Dimmeler
Aims Cardiac fibrosis drives the progression of heart failure in ischemic and hypertrophic cardiomyopathy. Therefore, the development of specific antifibrotic treatment regimens to counteract cardiac fibrosis is of high clinical relevance. Hence, this study examined the presence of persistent fibroblast activation during longstanding human heart disease at a single-cell resolution to identify putative
-
PDE4D mediates impaired β-adrenergic receptor signaling in the sinoatrial node in mice with hypertensive heart disease Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-29 Tristan W Dorey, Megan D McRae, Darrell D Belke, Robert A Rose
Aims The sympathetic nervous system increases HR by activating β-adrenergic receptors (β-ARs) and increasing cAMP in sinoatrial node (SAN) myocytes while phosphodiesterases (PDEs) degrade cAMP. Chronotropic incompetence, the inability to regulate heart rate (HR) in response to sympathetic nervous system activation, is common in hypertensive heart disease; however, the basis for this is poorly understood
-
Stroke risk management in carotid atherosclerotic disease: A Clinical Consensus Statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-23 Piotr Musialek, Leo H Bonati, Richard Bulbulia, Alison Halliday, Birgit Bock, Laura Capoccia, Hans-Henning Eckstein, Iris Q Grunwald, Peck Lin Lip, Andre Monteiro, Kosmas I Paraskevas, Anna Podlasek, Barbara Rantner, Kenneth Rosenfield, Adnan H Siddiqui, Henrik Sillesen, Isabelle Van Herzeele, Tomasz J Guzik, Lucia Mazzolai, Victor Aboyans, Gregory Y H Lip
Carotid atherosclerotic disease continues to be an important cause of stroke, often disabling or fatal. Such strokes could be largely prevented through optimal medical therapy and carotid revascularization. Advancements in discovery research and imaging along with evidence from recent pharmacology and interventional clinical trials and registries and the progress in acute stroke management have markedly
-
Genetic inactivation of β-catenin is salubrious whereas its activation is deleterious in desmoplakin cardiomyopathy Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-23 Melis Olcum, Siyang Fan, Leila Rouhi, Sirisha Cheedipudi, Benjamin Cathcart, Hyun-Hwan Jeong, Zhongming Zhao, Priyatansh Gurha, Ali J Marian
Aim Mutations in the DSP gene encoding desmoplakin, a constituent of the desmosomes at the intercalated discs (IDs), cause a phenotype that spans arrhythmogenic cardiomyopathy (ACM) and dilated cardiomyopathy (DCM). It is typically characterized by biventricular enlargement and dysfunction, myocardial fibrosis, cell death, and arrhythmias. The canonical WNT (cWNT)/β-catenin pathway is implicated in
-
Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-23 Matthias Bosman, Dustin Krüger, Charles Van Assche, Hanne Boen, Cédric Neutel, Kasper Favere, Constantijn Franssen, Wim Martinet, Lynn Roth, Guido De Meyer, Berta Cillero-Pastor, Leen Delrue, Ward Heggermont, Emeline Van Craenenbroeck, Pieter-Jan Guns
Aims Apart from cardiotoxicity, the chemotherapeutic doxorubicin (DOX) induces vascular toxicity, represented by arterial stiffness and endothelial dysfunction. Both parameters are of interest for cardiovascular risk stratification as they are independent predictors of future cardiovascular events in the general population. However, the time course of DOX-induced cardiovascular toxicity remains unclear
-
-
Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-21 Xiaoyin Wang, Meenakshi Gaur, Khalid Mounzih, Hilda J Rodriguez, Huiliang Qiu, Ming Chen, Liqiu Yan, Brian A Cooper, Shilpa Narayan, Ronak Derakhshandeh, Poonam Rao, Daniel D Han, Pooneh Nabavizadeh, Matthew L Springer, Constance M John
Aims Acute myocardial infarction (MI) causes inflammation, collagen deposition, and reparative fibrosis in response to myocyte death and, subsequently, a pathological myocardial remodelling process characterized by excessive interstitial fibrosis, driving heart failure (HF). Nonetheless, how or when to limit excessive fibrosis for therapeutic purposes remains uncertain. Galectin-3, a major mediator
-
C5a-C5aR1 induces endoplasmic reticulum stress to accelerate vascular calcification via PERK-eIF2α-ATF4-CREB3L1 pathway Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-21 Aiting Liu, Zhenwei Chen, Xiaoxue Li, Chen Xie, Yanlian Chen, Xiaoyan Su, Ying Chen, Mengbi Zhang, Jie Chen, Tiecheng Yang, Jiangang Shen, Hui Huang
Aims Vascular calcification (VC) predicts the morbidity and mortality in cardiovascular diseases. Vascular smooth muscle cells (VSMCs) osteogenic transdifferentiation is the crucial pathological basis for VC. To date, the molecular pathogenesis is still largely unclear. Notably, C5a-C5aR1 contributes to the development of cardiovascular diseases, and it’s closely related to physiological bone mineralization
-
Positron emission tomography imaging of inflammation in diabetes mellitus. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-19 Neil J Craig,Marc R Dweck
-
Targeting endothelial VCAM-1 in atherosclerosis: drug discovery and development of VCAM-1-directed novel therapeutics Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-18 Jess R Pickett, Yuao Wu, Lucia F Zacchi, Hang T Ta
Vascular cell adhesion molecule-1 (VCAM-1) has been well established as a critical contributor to atherosclerosis and consequently, as an attractive therapeutic target for anti-atherosclerotic drug candidates. Many publications have demonstrated that disrupting VCAM-1 function blocks monocyte infiltration into the subendothelial space, which effectively prevents macrophage maturation and foam cell
-
Activation of endothelial TRPM2 exacerbates blood-brain barrier degradation in ischemic stroke Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-18 Pengyu Zong, Jianlin Feng, Cindy X Li, Evan R Jellison, Zhichao Yue, Barbara Miller, Lixia Yue
Aims Damage of the blood-brain barrier (BBB) is a hallmark of brain injury during the early stages of ischemic stroke. The subsequent endothelial hyperpermeability drives the initial pathological changes and aggravates neuronal death. Transient receptor potential melastatin 2 (TRPM2) is a Ca2+-permeable nonselective cation channel activated by oxidative stress. However, whether TRPM2 is involved in
-
Sex-biased TGFβ signaling in pulmonary arterial hypertension Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-18 Marius Wits, Clarissa Becher, Frances de Man, Gonzalo Sanchez-Duffhues, Marie-José Goumans
Pulmonary arterial hypertension (PAH) is a rare cardiovascular disorder leading to pulmonary hypertension and, often fatal, right heart failure. Sex-differences in PAH are evident, which primarily presents with a female predominance and increased male severity. Disturbed transduction of the transforming growth factor-β (TGFβ) signaling family and gene mutations in the Bone morphogenetic protein receptor
-
Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-14 Grzegorz Kopeć
-
Mitochondrial pannexin1 controls cardiac sensitivity to ischaemia/reperfusion injury Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-09 Olga M Rusiecka, Filippo Molica, Morten S Nielsen, Axel Tollance, Sandrine Morel, Maud Frieden, Marc Chanson, Kerstin Boengler, Brenda R Kwak
Aims No effective therapy is available in clinics to protect the heart from ischaemia/reperfusion (I/R) injury. Endothelial cells are activated after I/R, which may drive the inflammatory response by releasing ATP through pannexin1 (Panx1) channels. Here, we investigated the role of Panx1 in cardiac I/R. Methods and results Panx1 was found in cardiac endothelial cells, neutrophils, and cardiomyocytes
-
p55γ degrades RIP3 via MG53 to suppress ischemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-01 Zhenyan Li, Rilei Dai, Min Chen, Lixuan Huang, Kun Zhu, Mingyang Li, Wenting Zhu, Yang Li, Ning Xie, Jingchen Li, Li Wang, Feng Lan, Chun-Mei Cao
Aims Regulated necrosis (necroptosis) and apoptosis are important biological features of myocardial infarction, ischemia-reperfusion (I/R) injury, and heart failure. However, the molecular mechanisms underlying myocardial necroptosis remain elusive. Ischemic preconditioning (IPC) is the most powerful intrinsic cardioprotection against myocardial I/R injury. In this study, we aimed to determine whether
-
FAM210A regulates mitochondrial translation and maintains cardiac mitochondrial homeostasis Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-31 Jiangbin Wu, Kadiam C Venkata Subbaiah, Omar Hedaya, Si Chen, Joshua Munger, Wai Hong Wilson Tang, Chen Yan, Peng Yao
Aims Mitochondria play a vital role in cellular metabolism and energetics and support normal cardiac function. Disrupted mitochondrial function and homeostasis cause a variety of heart diseases. Fam210a (family with sequence similarity 210 member A), a novel mitochondrial gene, is identified as a hub gene in mouse cardiac remodeling by multi-omics studies. Human FAM210A mutations are associated with
-
Immediate and sustained increases in the activity of vagal preganglionic neurons during exercise and after exercise training Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-30 Alla Korsak, Daniel O Kellett, Qadeer Aziz, Cali Anderson, Alicia D’Souza, Andrew Tinker, Gareth L Ackland, Alexander V Gourine
Background The brain controls the heart by dynamic recruitment and withdrawal of cardiac parasympathetic (vagal) and sympathetic activity. Autonomic control is essential for the development of cardiovascular responses during exercise, however, the patterns of changes in the activity of the two autonomic limbs, and their functional interactions in orchestrating physiological responses during exercise
-
LncRNA-encoded peptides: unveiling their significance in cardiovascular physiology and pathology - current research insights Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-30 Li Zhang, Mi Tang, Haoyang Diao, Liling Xiong, Xiao Yang, Shasha Xing
Long non-coding RNAs (lncRNAs), which are RNA transcripts exceeding 200 nucleotides, were believed to lack any protein-coding capacity. But advancements in -omics technology have revealed that some lncRNAs have small open reading frames (sORFs) that can be translated by ribosomes to encode peptides, some of which have important biological functions. These encoded peptides subserve important biological
-
Donor circadian clock influences the long-term survival of heart transplantation by immunoregulation Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-30 Wai Yen Yim, Tixiusi Xiong, Bingchuan Geng, Li Xu, Yu Feng, Jiangyang Chi, Ruikang Guo, Chenghao Li, Yuqi Chen, Jiawei Shi, Yixuan Wang, Nianguo Dong
Aims Circadian clocks play important role in immunoregulation. We aimed to investigate cardiac circadian clock specific pathways and compare cardiac grafts procured at different timing on survival after transplantation to explore novel criteria for donor selection. Methods and Results In primate heart, Phase Set Enrichment Analysis (PSEA) showed rhythmic transcripts were enriched in antigen processing
-
SGLT2 inhibitor canagliflozin alleviates vascular calcification through suppression of NLRP3 inflammasome Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-28 An Chen, Zirong Lan, Li Li, Luting Xie, Xiaoyu Liu, Xiulin Yang, Siyi Wang, Qingchun Liang, Qianqian Dong, Liyun Feng, Yining Li, Yuanzhi Ye, Mingwei Fu, Lihe Lu, Jianyun Yan
Aims Vascular calcification is prevalent in pathological processes such as diabetes, chronic kidney disease (CKD) and atherosclerosis, but effective therapies are still lacking by far. Canagliflozin (CANA), an SGLT2 inhibitor, has been approved for the treatment of type 2 diabetes mellitus and exhibits beneficial effects against cardiovascular disease. However, the effect of CANA on vascular calcification
-
Integrative human atrial modeling unravels interactive PKA and CaMKII signaling as key determinant of atrial arrhythmogenesis Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-28 Haibo Ni, Stefano Morotti, Xianwei Zhang, Dobromir Dobrev, Eleonora Grandi
Atrial fibrillation (AF), the most prevalent clinical arrhythmia, is associated with atrial remodeling manifesting as acute and chronic alterations in expression, function, and regulation of atrial electrophysiological and Ca2+-handling processes. These AF-induced modifications crosstalk and propagate across spatial scales creating a complex pathophysiological network, which renders AF resistant to
-
Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXCR2 Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-28 Kawthar Dhayni, Yuthiline Chabry, Lucie Hénaut, Carine Avondo, Cedric Boudot, Hakim Ouled-Haddou, Edith Bigot-Corbel, Gilles Touati, Thierry Caus, Hind Messaoudi, Jérémy Bellien, Christophe Tribouilloy, David Messika-Zeitoun, Kazem Zibara, Saïd Kamel, Youssef Bennis
Aims Inflammatory cytokines play a critical role in the progression of calcific aortic valve disease (CAVD), for which there is currently no pharmacological treatment. The aim of this study was to test the hypothesis that interleukin-8 (IL-8), known to be involved in arterial calcification, also promotes aortic valve calcification (AVC) and to evaluate whether pharmacologically blocking the IL-8 receptor
-
Genetic variation in SLC5A2 mimicking SGLT2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucose Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-28 Louise E Bechmann, Frida Emanuelsson, Børge G Nordestgaard, Marianne Benn
Aims Treatment with sodium-glucose co-transporter 2(SGLT2)-inhibitors reduces risk of cardiovascular disease and mortality, but the mechanism is unclear. We hypothesized that a functional genetic variant in SLC5A2, known to be associated with familial renal glucosuria, would mimic pharmacological SGLT2-inhibition, and thus provide an opportunity to examine potential mediators of the effects on lower
-
E-cigarettes and arrhythmogenesis: a comprehensive review of preclinical studies and their clinical implications Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-27 Carson A Jones, Michael J Wallace, Priya Bandaru, Emerson D Woodbury, Peter J Mohler, Loren E Wold
Electronic cigarette use has grown exponentially in recent years, and while their popularity has increased, the long-term effects on the heart are yet to be fully studied and understood. Originally designed as devices to assist with those trying to quit traditional combustible cigarette use, their popularity has attracted use by teens and adolescents who traditionally have not smoked combustible cigarettes
-
Epigenetic regulation of vascular smooth muscle cell phenotypic switch and neointimal formation by PRMT5 Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-24 Ni Zhu, Zhi-Fu Guo, Kyosuke Kazama, Bing Yi, Nopprarat Tongmuang, Huijun Yao, Ruifeng Yang, Chen Zhang, Yongwen Qin, Lin Han, Jianxin Sun
Aims Phenotypic transition of vascular smooth muscle cells (VSMCs) from a contractile to a synthetic state is involved in the development of cardiovascular diseases, including atherosclerosis, hypertension, and post-angioplasty restenosis. Arginine methylation catalyzed by protein arginine methyltransferases (PRMTs) has been implicated in multiple cellular processes, however, its role in VSMC biology
-
A machine learning based approach to identify carotid subclinical atherosclerosis endotypes. Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-21 Qiao Sen Chen,Otto Bergman,Louise Ziegler,Damiano Baldassarre,Fabrizio Veglia,Elena Tremoli,Rona J Strawbridge,Antonio Gallo,Matteo Pirro,Andries J Smit,Sudhir Kurl,Kai Savonen,Lars Lind,Per Eriksson,Bruna Gigante,
AIMS To define endotypes of carotid subclinical atherosclerosis. METHODS AND RESULTS We integrated demographic, clinical, and molecular data (n = 124) with ultrasonographic carotid measurements from study participants in the IMPROVE cohort (n = 3340). We applied a neural network algorithm and hierarchical clustering to identify carotid atherosclerosis endotypes. A measure of carotid subclinical atherosclerosis
-
Pathophysiology of the right ventricle in health and disease: an update Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-18 Khodr Tello, Robert Naeije, Frances de Man, Marco Guazzi
The contribution of the right ventricle (RV) to cardiac output is negligible in normal resting conditions when pressures in the pulmonary circulation are low. However, the RV becomes relevant in healthy subjects during exercise, and definitely so in patients with increased pulmonary artery pressures both at rest and during exercise. The adaptation of RV function to loading rests basically on an increased
-
RNA interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction Cardiovasc. Res. (IF 10.8) Pub Date : 2023-07-07 Tamara P Martin, Eilidh A MacDonald, Ashley Bradley, Holly Watson, Priyanka Saxena, Eva A Rog-Zielinska, Anmar Raheem, Simon Fisher, Ali Ali Mohamed Elbassioni, Ohood Almuzaini, Catriona Booth, Morna Campbell, Alex Riddell, Pawel Herzyk, Karen Blyth, Colin Nixon, Lorena Zentilin, Colin Berry, Thomas Braun, Mauro Giacca, Martin W McBride, Stuart A Nicklin, Ewan R Cameron, Christopher M Loughrey
Background Myocardial infarction is a major cause of death worldwide. Effective treatments are required to improve recovery of cardiac function following myocardial infarction, with the aim of improving patient outcomes and preventing progression to heart failure. The perfused but hypocontractile region bordering an infarct is functionally distinct from the remote surviving myocardium and is a determinant
-
Has genetic disposition implications for treatment decisions in atrial fibrillation? Cardiovasc. Res. (IF 10.8) Pub Date : 2023-08-07 Felix Bourier,Heribert Schunkert